Device and method for simultaneously identifying blood group antigens
The invention relates to a device for simultaneously, qualitatively or quantitatively identifying a number of analytes in a liquid sample. The device comprises a membrane with: a charging zone for applying the liquid sample; at least two indicator zones, which can interact with the analytes, and at least one absorption area, which absorbs the liquid after passing the indicator zones, whereby the indicator zones are located between the charging zone and an absorption area. The invention is characterized in that the flowing directions from the charging zone through the respective indicator zones to an absorption area (flow paths) are essentially parallel, and at least two different flow paths exist. The invention also relates to a method for identifying a number of analytes or the derivatives thereof in a liquid sample. The method consists of applying the sample to the charging zone of the membrane of the device, whereby this sample is present in an amount sufficient for causing the sample liquid to flow through the indicator zones toward the absorption area, and for causing the analytes or the derivatives thereof in the sample liquid to form a complex in the indicator zones.
1. A device for the simultaneous and qualitative or quantitative determination of a plurality of blood group antigens in a blood sample, the device consisting essentially of:
a single membrane having an application zone for the application of the blood sample, at least one group of at least two indicator zones, each indicator zone comprising a bonding element which is able to bind to the blood group antigen to be tested for, and at least one absorption region which takes up the blood after the blood passes through the group of indicator zones, wherein the indicator zones are located between the application zone and the at least one absorption region and are positioned on the membrane substantially parallel to each other and absent a liquid barrier between indicator zones, and wherein the blood group antigen bound to the bonding element is immobilized within the indicator zone.
2. The device according to claim 1 , wherein the indicator zones are arranged in a W-, M-, or N-shape or a linear row.
3. The device according to claim 1 , wherein the bonding elements comprise antibodies, lectines, or fragments thereof.
4. The device according to claim 3 , wherein the antibodies or fragments thereof specifically bind to a blood group antigen selected from the group consisting of A, B, AB, D, C, c, E, e, Cw, and K.
5. The device according to claim 1 , wherein the membrane consists of polyethylene, nitrocellulose or nylon.
6. The device according to claim 1 , wherein downstream of the application zone and upstream of the indicator zones at least one sealing element is provided on the membrane.
7. The device according to claim 1 , wherein the device is positioned onto a support layer.
8. The device according to claim 1 , wherein the device is integrated in a casing.
9. A device for the simultaneous and qualitative or quantitative determination of a plurality of blood group antigens in a blood sample, the device consisting essentially of:
a single membrane having an application zone for the application of the blood sample, at least one group of at least two indicator zones, each indicator zone comprising a bonding element which is able to bind to the blood group antigen to be tested for, and at least one absorption region which takes up the blood after the blood passes through the group of indicator zones, wherein the indicator zones are located between the application zone and the at least one absorption region and are positioned on the membrane diagonal to each other and absent a liquid barrier between indicator zones, and wherein the blood group antigen bound to the bonding element is immobilized within the indicator zone.
10. The device according to claim 9 , wherein the indicator zones are arranged in a diagonal V-, W-, M-, or N-shape.
11. The device according to claim 1 , comprising at least two groups of indicator zones and at least two absorption regions, wherein the application zone is positioned in the central region of the membrane.
12. The device according to claim 9 , comprising at least two groups of indicator zones and at least two absorption regions, wherein the application zone is positioned in the central region of the membrane.
13. The device according to claim 1 , further comprising an indicator zone comprising a control bonding element which indicates the flow of the blood sample through the indicator zones, wherein the control bonding element is an anti-erythrocyte antibody.
14. The device according to claim 9 , further comprising an indicator zone comprising a control bonding element which indicates the flow of the blood sample through the indicator zones, wherein the control bonding element is an anti-erythrocyte antibody.
15. A device for the simultaneous and qualitative or quantitative determination of a plurality of blood group antigens in a blood sample, the device consisting essentially of:
a single membrane having an application zone for the application of the blood sample, at least two groups of at least two indicator zones, each indicator zone comprising a bonding element, which is able to bind to the blood group antigen to be tested for, and at least two absorption regions which takes up the blood after the blood passes through the group of indicator zones, wherein the application zone is positioned in a central region of the membrane, the indicator zones are located between the application zone and the at least one absorption region and are positioned on the membrane substantially parallel to each other and absent a liquid barrier between indicator zones, and wherein the blood group antigen bound to the bonding element is immobilized within the indicator zone.
16. A device for the simultaneous and qualitative or quantitative determination of a plurality of blood group antigens in a blood sample, the device consisting of:
a single membrane having an application zone for the application of the blood sample, at least one group of at least two indicator zones, each indicator zone comprising a bonding element which is able to bind to the blood group antigen to be tested for, and at least one absorption region which takes up the blood after the blood passes through the group of indicator zones, wherein the indicator zones are located between the application zone and the at least one absorption region and are positioned on the membrane substantially parallel to each other and absent a liquid barrier between indicator zones, and wherein the blood group antigen bound to the bonding element is immobilized within the indicator zone.